title: Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.
abstract: Nonalcoholic fatty liver disease (NAFLD), defined by excessive liver fat deposition related to the metabolic syndrome, is a leading cause of progressive liver disease, for which accurate non-invasive staging systems and effective treatments are still lacking. Evidence has shown that increased ferritin levels are associated with the metabolic insulin resistance syndrome, and higher hepatic iron and fat content. Hyperferritinemia and iron stores have been associated with the severity of liver damage in NAFLD, and iron depletion reduced insulin resistance and liver enzymes. Recently, Kowdley et al demonstrated in a multicenter study in 628 adult patients with NAFLD from the NAFLD-clinical research network database with central re-evaluation of liver histology and iron staining that the increased serum ferritin level is an independent predictor of liver damage in patients with NAFLD, and is useful to identify NAFLD patients at risk of non-alcoholic steatohepatitis and advanced fibrosis. These data indicate that incorporation of serum ferritin level may improve the performance of noninvasive scoring of liver damage in patients with NAFLD, and that iron depletion still represents an attractive therapeutic target to prevent the progression of liver damage in these patients.
authors.affiliation: Università degli Studi di Milano, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico, Milan, Italy. luca.valenti@unimi.it
authors.forename: Luca
authors.initials: L
authors.lastname: Valenti
authors.forename: Paola
authors.initials: P
authors.lastname: Dongiovanni
authors.forename: Silvia
authors.initials: S
authors.lastname: Fargion
mesh_terms: D005234:Fatty Liver / Q000097:blood* / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D005293:Ferritins / Q000097:blood*; D006801:Humans; D007333:Insulin Resistance; D019190:Iron Overload / Q000378:metabolism; D008099:Liver / Q000378:metabolism / Q000473:pathology; D024821:Metabolic Syndrome / Q000378:metabolism; D008954:Models, Biological; D065626:Non-alcoholic Fatty Liver Disease; D018962:Phlebotomy
chemical_list: D005293:Ferritins